1
|
Jones JM, Howell D, Longo C, Olson K, Bedard P, Amir E, Zheng S, Chow B, Avery L. The association of cancer-related fatigue on the social, vocational and healthcare-related dimensions of cancer survivorship. J Cancer Surviv 2023:10.1007/s11764-023-01451-9. [PMID: 37644355 DOI: 10.1007/s11764-023-01451-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2023] [Accepted: 08/14/2023] [Indexed: 08/31/2023]
Abstract
BACKGROUND Cancer-related fatigue (CRF) is well documented in cancer survivors, but little is known about the personal and societal impact of CRF. This study aimed to examine the impact of CRF in relation to social and vocational functioning and health care utilization in a large sample of post-treatment cancer survivors. METHODS We conducted a cross-sectional descriptive study of early stage breast and colorectal cancer survivors (n = 454) who were within 5 years from treatment completion. Social difficulties (SDI-21), work status, absenteeism and presenteeism (WHO-HPQ) and healthcare utilization (HSUQ) were compared in those with (CFR +) and without (CRF -) clinically significant fatigue (FACT-F ≤ 34). RESULTS A total of 32% met the cut-off criteria for CRF (≤ 34). Participants with CRF + had significantly higher scores on the SDI-21 across all domains and 55% of CRF + vs. 11% in CRF - was above the SDI cut-off (> 10) for significant social difficulties. Participants with CRF + were 2.74 times more likely to be unemployed or on leave (95% CI 1.62, 4.61, p < 0.001). In the subgroup of participants who were currently working (n = 249), those with CRF + reported working on average 27.4 fewer hours in the previous 4 weeks compared to CRF - (p = 0.05), and absolute presenteeism was on average 13% lower in the CRF + group (95% CI 8.0, 18.2, p < 0.001). Finally, individuals with CRF + reported significantly more physician (p < 0.001), other health care professional (p = 0.03) and psychosocial visits (p = 0.002) in the past month. CONCLUSIONS AND IMPLICATIONS FOR CANCER SURVIVORS CRF is associated with substantial disruption in social and work role functioning in the early transitional phase of cancer survivorship. Better management of persistent CRF and funding for the implementation of existing guidelines and recommended evidence-based interventions are urgently needed.
Collapse
Affiliation(s)
- Jennifer M Jones
- Cancer Rehabilitation and Survivorship Program, Princess Margaret Cancer Centre and Department of Psychiatry, University of Toronto, 200 Elizabeth Street, B-PMB-045, Toronto, ON, M5G 2C4, Canada.
| | - Doris Howell
- Department of Supportive Care, Princess Margaret Cancer Centre and Lawrence Bloomberg Faculty of Nursing, University of Toronto, Toronto, Canada
| | - Christopher Longo
- Health Policy and Management, DeGroote School of Business, McMaster University, Hamilton, Canada
| | - Karin Olson
- Faculty of Nursing, University of Alberta, and Edmonton Clinic Health Academy, Edmonton, Canada
| | - Philippe Bedard
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada
| | - Eitan Amir
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada
| | - Shiyu Zheng
- MD Program, University of Toronto, Toronto, Canada
| | - Brittany Chow
- Department of Family and Community Medicine, University of Toronto, Toronto, Canada
| | - Lisa Avery
- Department of Biostatistics, Princess Margaret Cancer Centre, and Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| |
Collapse
|
2
|
Da'ar OB, Jradi H, Alkaiyat M, Alolayan A, Jazieh AR. Social Distress among Cancer Patients: Differential Effects of Risk Factors and Attenuating Role of Culturally Specific Social Support. Healthcare (Basel) 2023; 11:1876. [PMID: 37444710 DOI: 10.3390/healthcare11131876] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2023] [Revised: 06/16/2023] [Accepted: 06/24/2023] [Indexed: 07/15/2023] Open
Abstract
Introduction: We investigated the association between social distress or toxicity and patients' clinical conditions, demographic characteristics, and social support and networks, and whether this association differs along the distribution of patients' distress levels. This study included 156 patients treated at King Abdulaziz Medical City, Riyadh, Saudi Arabia. Methods: We used the previously validated Social Toxicity Assessment Tool in Cancer (STAT-C) to assess cancer patients' distress. We analyzed distress level, the outcome variable of interest, and covariates to show distribution and identify associations. We then used logistic quantile regression for bounded outcomes to assess the association between social distress or toxicity and patients' clinical conditions, demographic characteristics, and social support and network. As an extension, we examined the interaction between disease status and social support, focusing on the moderating role of social support in attenuating the impact of disease status on social distress. Results: The median age of the patients was 51.2 (SD = 21.4, range 22 to 89), with 48.1% being older than 50 years. Of the 156 cancer patients analyzed, 82 (52.6%) were classified as burdened, and 50% of those with uncontrolled disease status were socially distressed. However, there were more socially distressed patients diagnosed within a year and patients undergoing treatment. There was a greater number of patients who shared their diagnosis with family, colleagues, and neighbors with social distress. The odds of suffering from social distress were higher in younger patients (50 years or younger) than in older patients. Social distress was lower in patients who underwent combined chemotherapy, surgery, and radiation compared with patients who received a single treatment regimen (OR = 0.65, CI, -0.820 to -0.036, p = 0.033). The odds of social distress were 67% higher in patients diagnosed within one year than in patients diagnosed more than one year prior (OR = 1.664, CI, 0.100-0.918, p = 0.015). Patients with uncontrolled disease conditions who shared their diagnosis and treatment with social networks were 48% less likely to experience social distress. Thus, sharing cancer diagnoses with social networks has a statistically significant moderating effect by attenuating the impact of disease status on social distress. Conclusion: Understanding the risk factors for social distress may be important for cancer management. Additionally, identifying the moderating role that patients' sharing of cancer diagnoses in social networks plays in attenuating the impact of disease status on social distress may provide healthcare providers with valuable insights for holistic culture-specific care.
Collapse
Affiliation(s)
- Omar B Da'ar
- Department of Health Systems Management, College of Public Health and Health Informatics, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia
- King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia
| | - Hoda Jradi
- King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia
- Department of Community and Environmental Health, College of Public Health and Health Informatics, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia
| | - Mohammad Alkaiyat
- King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia
- Department of Oncology, King Abdulaziz Medical City, Riyadh 11426, Saudi Arabia
| | - Ashwaq Alolayan
- King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia
- Department of Oncology, King Abdulaziz Medical City, Riyadh 11426, Saudi Arabia
| | | |
Collapse
|
3
|
Jazieh AR, Jradi H, Da'ar OB, Alkaiyat M, Zafar Y, Alolayan A. Developing, Implementing, and Validating a Social Toxicity Assessment Tool of Cancer. JCO Glob Oncol 2021; 7:1522-1528. [PMID: 34726956 PMCID: PMC8563070 DOI: 10.1200/go.21.00170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
The social impact of cancer on patients and their family is well known. Yet, unlike with physical and financial toxicities, no validated tools are available to measure this impact. This study aimed at developing, validating, and implementing a novel social toxicity assessment tool for patients with cancer diagnosis (STAT-C).
Collapse
Affiliation(s)
- Abdul-Rahman Jazieh
- Cincinnati Cancer Advisors, Cincinnati, OH.,Department of Oncology, King Saud bin Abdulaziz University for Health Sciences, and King Abdullah International Medical Research Center, Ministry of National Guards for Health Affairs, Riyadh, Saudi Arabia
| | - Hoda Jradi
- College of Public Health, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Ministry of National Guards for Health Affairs, Riyadh, Saudi Arabia
| | - Omar B Da'ar
- College of Public Health, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Ministry of National Guards for Health Affairs, Riyadh, Saudi Arabia
| | - Mohammad Alkaiyat
- Department of Oncology, King Saud bin Abdulaziz University for Health Sciences, and King Abdullah International Medical Research Center, Ministry of National Guards for Health Affairs, Riyadh, Saudi Arabia
| | - Yousuf Zafar
- Division of Hematology Oncology, Duke University, Durham, NC
| | - Ashwaq Alolayan
- Department of Oncology, King Saud bin Abdulaziz University for Health Sciences, and King Abdullah International Medical Research Center, Ministry of National Guards for Health Affairs, Riyadh, Saudi Arabia
| |
Collapse
|
6
|
Hisamura K, Matsushima E, Tsukayama S, Murakami S, Motoo Y. An exploratory study of social problems experienced by ambulatory cancer patients in Japan: Frequency and association with perceived need for help. Psychooncology 2018. [PMID: 29528536 DOI: 10.1002/pon.4703] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Little is known about the social problems experienced by cancer patients in non-Western countries. The aims of this study were (1) to explore the characteristics and frequencies of social problems in cancer outpatients, as well as their associations with the need for help, and (2) to take the initial steps to develop an instrument for the assessment of cancer-related social problems in Japan. METHODS A cross-sectional group of 109 patients completed the Social Problem Checklist and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30. Participants rated the levels of the problem severity and the need for help on each item. Factor structure, internal consistency, and construct validity were also assessed. RESULTS In total, 72.5% of the participants encountered ≥1 problem, and 33% experienced ≥1 serious problem. The amount of help needed tended to be lower than problem severity, especially for family and social life issues. The most common reason for not needing help, as reported by approximately 40% of patients who experienced problems, was the preference for self-management. A 3-factor model was extracted that included financial matters, medical information, and family and social life. Excellent internal consistencies for each factor and convergent correlations between the relevant subscales of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 and Social Problem Checklist were confirmed. CONCLUSIONS A substantial proportion of participants had cancer-related social problems, but they had ambivalent help-related needs. Interventions that enhance the patient's abilities for self-care could be essential to help cancer outpatients manage social problems in Japan.
Collapse
Affiliation(s)
- Kazuho Hisamura
- Department of Medical Oncology, Kanazawa Medical University, Ishikawa, Japan
| | - Eisuke Matsushima
- Section of Liaison Psychiatry and Palliative Medicine, Graduate School of Medical and Dental Science, Tokyo Medical and Dental University, Tokyo, Japan
| | | | - Shinya Murakami
- Department of Surgery, Komatsu Municipal Hospital, Komatsu, Japan
| | - Yoshiharu Motoo
- Department of Medical Oncology, Kanazawa Medical University, Ishikawa, Japan
| |
Collapse
|
9
|
Wright P, Downing A, Morris EJA, Corner JL, Richards MA, Sebag-Montefiore D, Finan P, Glaser AW. Identifying Social Distress: A Cross-Sectional Survey of Social Outcomes 12 to 36 Months After Colorectal Cancer Diagnosis. J Clin Oncol 2015; 33:3423-30. [PMID: 26282636 DOI: 10.1200/jco.2014.60.6129] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
PURPOSE To establish the prevalence and determinants of poor social outcomes after a diagnosis of colorectal cancer (CRC). PATIENTS AND METHODS All 12- to 36-month survivors of CRC (International Classification of Diseases [10th revision] codes C18 to C20) diagnosed in 2010 or 2011 and treated in the English National Health Service were identified and sent a questionnaire from their treating cancer hospital. This included the Social Difficulties Inventory, a 16-item scale of social distress (SD) comprising everyday living, money matters, and self and others subscales, plus five single items. Sociodemographic and clinical data were also collected. Analyses using descriptive statistics, χ(2) tests, and logistic regression models were conducted. RESULTS Response rate was 63.3% (21,802 of 34,467). Of the 21,802 participants, 17,830 (81.8%) completed all SD items; 2,688 (15.1%) of these 17,830 respondents were classified as experiencing SD (everyday living, 19.5%; money matters, 15.6%; self and others, 18.1%). Multivariable analysis demonstrated having ≥ three long-term conditions was the strongest predictor of SD (odds ratio [OR], 6.64; 95% CI, 5.67 to 7.77 compared with no long-term conditions), followed by unemployment (OR, 5.11; 95% CI, 4.21 to 6.20 compared with being employed), having recurrent or nontreatable disease (OR, 2.75; 95% CI, 2.49 to 3.04 compared with being in remission), and having a stoma (OR, 2.10; 95% CI, 1.86 to 2.36 compared with no stoma). Additional predictors of SD were young age (< 55 years), living in a more deprived area, nonwhite ethnicity, having advanced-stage disease, having undergone radiotherapy, and being a carer. CONCLUSION Although it is reassuring a majority do not experience social difficulties, a minority reported significant SD 12 to 36 months after diagnosis of CRC. The identified clinical and social risk factors are easy to establish and should be used to target support.
Collapse
Affiliation(s)
- Penny Wright
- Penny Wright, Amy Downing, Eva J.A. Morris, David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, University of Leeds, St James's University Hospital; David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, Leeds Teaching Hospitals National Health Service Trust, St James's University Hospital, Leeds; Jessica L. Corner, University of Southampton, Highfield, Southampton; Mike A. Richards, Care Quality Commission; and Paul Finan, National Cancer Intelligence Network, London, United Kingdom.
| | - Amy Downing
- Penny Wright, Amy Downing, Eva J.A. Morris, David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, University of Leeds, St James's University Hospital; David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, Leeds Teaching Hospitals National Health Service Trust, St James's University Hospital, Leeds; Jessica L. Corner, University of Southampton, Highfield, Southampton; Mike A. Richards, Care Quality Commission; and Paul Finan, National Cancer Intelligence Network, London, United Kingdom
| | - Eva J A Morris
- Penny Wright, Amy Downing, Eva J.A. Morris, David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, University of Leeds, St James's University Hospital; David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, Leeds Teaching Hospitals National Health Service Trust, St James's University Hospital, Leeds; Jessica L. Corner, University of Southampton, Highfield, Southampton; Mike A. Richards, Care Quality Commission; and Paul Finan, National Cancer Intelligence Network, London, United Kingdom
| | - Jessica L Corner
- Penny Wright, Amy Downing, Eva J.A. Morris, David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, University of Leeds, St James's University Hospital; David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, Leeds Teaching Hospitals National Health Service Trust, St James's University Hospital, Leeds; Jessica L. Corner, University of Southampton, Highfield, Southampton; Mike A. Richards, Care Quality Commission; and Paul Finan, National Cancer Intelligence Network, London, United Kingdom
| | - Mike A Richards
- Penny Wright, Amy Downing, Eva J.A. Morris, David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, University of Leeds, St James's University Hospital; David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, Leeds Teaching Hospitals National Health Service Trust, St James's University Hospital, Leeds; Jessica L. Corner, University of Southampton, Highfield, Southampton; Mike A. Richards, Care Quality Commission; and Paul Finan, National Cancer Intelligence Network, London, United Kingdom
| | - David Sebag-Montefiore
- Penny Wright, Amy Downing, Eva J.A. Morris, David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, University of Leeds, St James's University Hospital; David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, Leeds Teaching Hospitals National Health Service Trust, St James's University Hospital, Leeds; Jessica L. Corner, University of Southampton, Highfield, Southampton; Mike A. Richards, Care Quality Commission; and Paul Finan, National Cancer Intelligence Network, London, United Kingdom
| | - Paul Finan
- Penny Wright, Amy Downing, Eva J.A. Morris, David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, University of Leeds, St James's University Hospital; David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, Leeds Teaching Hospitals National Health Service Trust, St James's University Hospital, Leeds; Jessica L. Corner, University of Southampton, Highfield, Southampton; Mike A. Richards, Care Quality Commission; and Paul Finan, National Cancer Intelligence Network, London, United Kingdom
| | - Adam W Glaser
- Penny Wright, Amy Downing, Eva J.A. Morris, David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, University of Leeds, St James's University Hospital; David Sebag-Montefiore, Paul Finan, and Adam W. Glaser, Leeds Teaching Hospitals National Health Service Trust, St James's University Hospital, Leeds; Jessica L. Corner, University of Southampton, Highfield, Southampton; Mike A. Richards, Care Quality Commission; and Paul Finan, National Cancer Intelligence Network, London, United Kingdom
| |
Collapse
|